Completed NA INTERVENTIONAL 2-arm NCT02971995

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies (PROSTEPIRM)

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies in Prostate Cancer Patients

Sponsor: Lille Catholic University

Conditions Fluorocholine Positron-Emission Tomography Prostatic Neoplasm

Updated 5 times since 2017 Last updated: Nov 21, 2016 Started: Dec 31, 2014 Primary completion: Mar 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Fluorocholine and Positron-Emission Tomography and is currently completed. Lille Catholic University leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lille Catholic University

Data source: Lille Catholic University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.